| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Traceable | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.11M | Series B-3 | 5/1/2024 | $29.05M | $493.39M | $4.55 | Citi Ventures, IVP, Geodesic Capital, Sorenson Capital, Unusual Ventures | ||||
 | TriSalus Life Sciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $198.81M | Series B-2 | 10/5/2022 | $15.32M | $375.88M | $0.35 | Undisclosed Investors | ||||
 | Untapped | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $68.5M | Series C | 9/14/2021 | $45M | $400.31M | $9.61 | Owl Ventures, Sequoia, HighSage Ventures, Zoom Apps Fund, Fifth Down Capital, BAM Elevate, Lachy Groom | ||||
 | Vendelux | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $66.45M | Series B | 7/8/2026 | $42.06M | $253.39M | $13.49 | Tribeca Venture Partners, S3 Ventures, Pelion Venture Partners, HubSpot Ventures, FirstMark Capital, Cervin Ventures, Correlation Ventures, Alumni Ventures | ||||
 | AZTherapies | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $121.38M | Series C-1 | 8/28/2020 | $35M | $401.38M | $6.75 | Duopharma Biotech Berhad, Spinnaker Capital, ID Fund, DRADS Capital, Wexford Capital, Nextrans-KCLAVIS, Axiom Associates, DEFTA Partners | ||||
 | Balbix | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $105.09M | Series C Prime | 3/1/2022 | $46.49M | $244.75M | $2.42 | Redline Capital, Third Point Ventures, Nautilus Venture Partners, Modern Venture Partners, Franklin Park, Mayfield, JC2 Ventures, Mubadala Capital, Alter Venture Partners, Singtel Innov8 | ||||
 | Bardy Diagnostics | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $84.02M | Series B-1 | 2/14/2020 | $13M | $132.82M | $1.30 | River Cities Capital Funds, SV Health Investors, Health Enterprise Partners | ||||
 | BarkBox | Consumer & Lifestyle Other Consumer & Lifestyle | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $67.36M | Series C | 12/21/2016 | $37.32M | $270.22M | $17.42 | August Capital, Founders Circle Capital, Resolute Ventures, RRE Ventures | ||||
 | Bitglass | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $156.51M | Series D | 4/8/2019 | $76M | $476.27M | $7.38 | Quadrille Capital, Future Fund, SingTel Innov8, Norwest Venture Partners, New Enterprise Associates | ||||
 | Blee | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $27.49M | Series A-1 Nonvoting | 9/8/2026 | $10M | $270.76M | $2.75 | Fin Capital, SMBC, Hannah Grey VC, National Bank of Canada, Y Combinator, Penny Jar Capital, Cardumen Capital, Treasury | ||||
 | Bromium | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $115.62M | Series D | 3/24/2016 | $75.22M | $240.61M | $1.21 | Ignition Partners, Highland Capital Partners, Intel Capital Lightspeed Venture Partners, Meritech Capital Partners, Silver Lake Technology Management | ||||
 | Clarifai | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $100.08M | Series C | 10/15/2021 | $58.44M | $426.19M | $16.15 | New Enterprise Associates, Menlo Ventures, Union Square Ventures, Lux Capital, LDV Capital, Corazon Capital, NYU Innovation Venture Fund, CPP Investments, NextEquity Partners, SineWave Ventures, Trousdale Capital | ||||
 | Codiak BioSciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $168.37M | Series C | 11/29/2017 | $76.37M | $404.14M | $3.78 | ARCH Venture Partners, Flagship Pioneering, Fidelity Management and Research Company, the Alaska Permanent Fund, Alexandria Venture Investments | ||||
 | Enlaza Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $176M | Series A-1 | 9/11/2025 | $15M | $291.63M | $1.25 | Undisclosed Investors | ||||
 | Escient Pharmaceuticals | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $243.51M | Series C | 11/28/2022 | $120M | $256.49M | $0.75 | NEA, Abingworth, Forge Life Science Partners, Avego, PFM Health Sciences, The Eleven Fund, The Column Group, 5AM Ventures, Redmile Group, Cowen Healthcare Investments, Sanofi Ventures, Osage University Partners, Altitude Life Science Ventures | ||||
 | Factual | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $198.58M | Series B-1 | 9/5/2018 | $37.12M | $240.28M | $6.37 | Upfront Ventures, Felicis Ventures and other undisclosed investors | ||||
 | Fast Radius | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $61.21M | Series B | 4/2/2019 | $48.02M | $392.68M | $13.49 | Drive Capital, Hyde Park Venture Partners, Jump Capital, SkyDeck, UPS Strategic Enterprise Fund | ||||
 | FiveStars | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $128.11M | Series D | 10/15/2020 | $35M | $285.44M | $1.32 | Salt Partners, Lightspeed Venture Partners, DCM Ventures, Menlo Ventures, HarbourVest Partners | ||||
 | Fluid Truck | Transportation Ridesharing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $161.87M | Series B | 6/14/2023 | $2.77M | $404.71M | $12.30 | Undisclosed Investors | ||||
 | Goldfinch Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $190.22M | Series B | 6/30/2020 | $105.91M | $252.06M | $1.18 | Eventide Asset Management, Wellington Management Company, Ally Bridge Group, BlackRock, Casdin Capital, Irving Investors, Gilead Sciences, Yonjin Capital, Schroeder Adveq | ||||
 | Groundspeed Analytics | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $95.69M | Series D-B | 3/10/2023 | $29.98M | $360.12M | $1.84 | Undisclosed Investors | ||||
 | Halio | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $418.69M | Series D | 1/30/2019 | $200M | $389.38M | $1.27 | SK Holdings, 5AM Ventures, Alexandria Real Estate, Capricorn Investment Group, Versant Ventures | ||||
 | Heyday | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $865.61M | Series E-2 | 8/30/2024 | $15.11M | $386.5M | $8.23 | Undisclosed Investors | ||||
 | HI-Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $22.2M | Series A | 10/20/2022 | $20M | $97.78M | $0.71 | Tom Brown, Jonas Schneider, Drew Houston, Arash Ferdowsi, Astera Institute | ||||